# Arrowhead Pharmaceuticals, Inc.: Form 8-K, filed Jun 16, 2026

- Company: [Arrowhead Pharmaceuticals, Inc.](/companies/arwr.md) (CIK 879407)
- Form: 8-K
- Filed: 2026-06-16
- Accepted by EDGAR: Jun 16, 2026, 16:02 ET
- Period: 2026-06-12
- Accession: 0000879407-26-000050
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/879407/000087940726000050/arwr-20260612.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/879407/000087940726000050/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/879407/000087940726000050/arwr-20260612.htm

Filed Jun 16, 2026.
Source: SEC EDGAR, the filing index for accession 0000879407-26-000050. Last ingested by Listed: Nov 5, 2026, 13:51 ET. No prices; not investment advice.